Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT: Hydroxychloroquine, Oseltamivir, and Azithromycin for COVID-19
NCT04338698Phase 3Completed
- Start
- Apr 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, oseltamivir, azithromycin in coronavirus disease 2019 (COVID-19). Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquineoseltamivirazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04338698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338698.